These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19994512)

  • 41. Application of imaging-derived parameters to dosimetry of intravascular brachytherapy sources: perturbation effects of residual plaque burden.
    Sehgal V; Li Z; Palta JR; Smith KM; Bolch WE
    Med Phys; 2002 Jul; 29(7):1580-9. PubMed ID: 12148741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 90Y PET-based dosimetry after selective internal radiotherapy treatments.
    D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O
    Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-rate distribution of 32P-glass microspheres for intra-arterial brachytherapy.
    Guimarães CC; Moralles M; Sene FF; Martinelli JR
    Med Phys; 2010 Feb; 37(2):532-9. PubMed ID: 20229861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of cystic craniopharyngiomas with intracavitary irradiation with 32P.
    Shahzadi S; Sharifi G; Andalibi R; Zali A; Ali-Asgari A
    Arch Iran Med; 2008 Jan; 11(1):30-4. PubMed ID: 18154420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. S-factor calculations for mouse models using Monte-Carlo simulations.
    Bitar A; Lisbona A; Bardiès M
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):343-51. PubMed ID: 17538523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimation of radiation dose at various depths for commonly used radionuclides in radiosynoviorthesis in a tissue equivalent material.
    Tandon P; Malpani BL; Venkatesh M; Bhatt BC
    Med Phys; 2006 Aug; 33(8):2744-50. PubMed ID: 16964849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative Monte Carlo-based 90Y SPECT reconstruction.
    Elschot M; Lam MG; van den Bosch MA; Viergever MA; de Jong HW
    J Nucl Med; 2013 Sep; 54(9):1557-63. PubMed ID: 23907758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absorbed dose profiles for (32)P, (90)Y, (188)Re, (177)Lu, (153)Sm and (169)Er: radionuclides used in radiosynoviortheses treatment.
    Torres M; Ayra E; Albuerne O; Montano Delgado MA
    Rev Esp Med Nucl; 2009; 28(4):188-92. PubMed ID: 19922831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multicellular dosimetry in voxel geometry for targeted radionuclide therapy.
    Malaroda A; Flux GD; Buffa FM; Ott RJ
    Cancer Biother Radiopharm; 2003 Jun; 18(3):451-61. PubMed ID: 12954133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bremsstrahlung imaging after 32P treatment for residual suprasellar cyst.
    Balachandran S; McGuire L; Flanigan S; Shah H; Boyd CM
    Int J Nucl Med Biol; 1985; 12(3):215-21. PubMed ID: 3877705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dosimetry characterization of 32P catheter-based vascular brachytherapy source wire.
    Mourtada FA; Soares CG; Seltzer SM; Lott SH
    Med Phys; 2000 Aug; 27(8):1770-6. PubMed ID: 10984223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Monte Carlo code MCPTV--Monte Carlo dose calculation in radiation therapy with carbon ions.
    Karg J; Speer S; Schmidt M; Mueller R
    Phys Med Biol; 2010 Jul; 55(13):3917-36. PubMed ID: 20571213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
    Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
    J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dosimetric effect of source centering and residual plaque for beta-emitting catheter based intravascular brachytherapy sources.
    Sehgal V; Li Z; Palta JR; Bolch WE
    Med Phys; 2001 Oct; 28(10):2162-71. PubMed ID: 11695779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phantom size in brachytherapy source dosimetric studies.
    Pérez-Calatayud J; Granero D; Ballester F
    Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Stereotactic intratumoral irradiation of huge craniopharyngioma].
    Tian Z; Liu Z; Wang Y
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):234-6. PubMed ID: 9387264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monte Carlo derivation of AAPM TG-43 dosimetric parameters for GZP6 Co-60 HDR sources.
    Tabrizi SH; Asl AK; Azma Z
    Phys Med; 2012 Apr; 28(2):153-60. PubMed ID: 21624844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.